Multivisceral resection for primary locally advanced rectal carcinoma

British Journal of Surgery

Volumn 98, Issue 4, 2011, Pages 582-588

  Harris, D A ^a   Davies, M ^a   Lucas, M G ^a   Drew, P ^a   Carr, N D ^a   Beynon, J ^a  

^a SINGLETON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; FEMALE; HUMAN; KAPLAN MEIER METHOD; LENGTH OF STAY; MALE; MIDDLE AGED; MORTALITY; RECTUM TUMOR; TREATMENT OUTCOME; TUMOR RECURRENCE; VISCERA;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; TREATMENT OUTCOME; VISCERA;

EID: 79951961103     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7373     Document Type: Article

References (24)

1. Cancel Research UK. Bowel (Colorectal) Cancera UK Incidence Statistics. [accessed 17 October 2009].
2. MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006; 333: 779.
3. Cancer Services Coordinating Group Fourth Bowel Cancer Audit Report. Bowel Cancer: Presentation, Treatment and Outcomes in Wales April 07-March 08. [accessed 17 October 2009].
4. Birbeck KF, Macklin CP, Tiffin NJ, Parsons W, Dixon MF, Mapstone NP, et al., Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002; 235: 449-457. (Pubitemid 34258342)
5. Wibe A, Rendedal PR, Svensson E, Norstein J, Eide TJ, Myrvold HE, et al., Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002; 89: 327-334. (Pubitemid 34227032)
6. Bernstein TE, Endreseth BH, Romundstad P, Wibe A,; Norwegian Colorectal Cancer Group. Circumferential resection margin as a prognostic factor in rectal cancer. Br J Surg 2009; 96: 1348-1357.
7. Brunschwig A,. Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into colon above the colostomy. Cancer 1948; 1: 177-183.
8. Ishiguro S, Akasu T, Fujita S, Yamamoto S, Kusters M, Moriya Y,. Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period. Surgery 2009; 145: 189-195.
9. Gannon CJ, Zager JS, Chang GJ, Feig BW, Wood CG, Skibber JM, et al., Pelvic exenteration affords safe and durable treatment for locally advanced rectal cancer. Ann Surg Oncol 2007; 14: 1870-1877. (Pubitemid 46870946)
10. Nguyen DQ, McGregor AD, Freites O, Carr ND, Beynon J, El-Sharkawi AM, et al., Exenterative pelvic surgerya eleven year experience of the Swansea Pelvic Oncology Group. Eur J Surg Oncol 2005; 31: 1180-1184. (Pubitemid 41819205)
11. Kaplan EL, Meier P,. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
12. Stricker D,. BrightStat.com: free statistics online. Comput Methods Programs Biomed 2008; 92: 135-143.
13. Larsen SG, Wiig JN, Tretli S, Giercksky KE,. Surgery and pre-operative irradiation for locally advanced or recurrent rectal cancer in patients over 75 years of age. Colorectal Dis 2006; 8: 177-185. (Pubitemid 43379501)
14. Ferenschild FT, Vermaas M, Verhoef C, Ansink AC, Kirkels WJ, Eggermont AM, et al., Total pelvic exenteration for primary and recurrent malignancies. World J Surg 2009; 33: 1502-1508.
15. Klautke G, Feyerherd P, Ludwig K, Prall F, Foitzik T, Fietkau R,. Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer. Br J Cancer 2005; 92: 1215-1220. (Pubitemid 40604394)
16. Ratto C, Valentini V, Morganti AG, Barbaro B, Coco C, Sofo L, et al., Combined-modality therapy in locally advanced primary rectal cancer. Dis Colon Rectum 2003; 46: 59-67. (Pubitemid 36105832)
17. Theodoropoulos G, Wise WE, Padmanabhan A, Kerner BA, Taylor CW, Aguilar PS, et al., T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 2002; 45: 895-903. (Pubitemid 34761469)
18. Janjan NA, Crane CN, Feig BW, Cleary K, Dubrow R, Curley SA, et al., Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2000; 47: 713-718. (Pubitemid 30317490)
19. Kaminsky-Forrett MC, Conroy T, Luporsi E, Peiffert D, Lapeyre M, Boissel P, et al., Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys 1998; 5: 935-941. (Pubitemid 29004132)
20. Ike H, Shimada H, Yamaguchi S, Ichikawa Y, Fujii S, Ohki S,. Outcome of total pelvic exenteration for primary rectal cancer. Dis Colon Rectum 2003; 46: 474-480. (Pubitemid 36428042)
21. Law WL, Chu KW, Choi HK,. Total pelvic exenteration for locally advanced rectal cancer. J Am Coll Surg 2000; 190: 78-83. (Pubitemid 30020579)
22. Derici H, Unalp HR, Kamer E, Bozdag AD, Tansug T, Nazli O, et al., Multivisceral resections for locally advanced rectal cancer. Colorectal Dis 2008; 10: 453-459. (Pubitemid 351682172)
23. Sanfilippo NJ, Crane CH, Skibber J, Feig B, Abbruzzese JL, Curley S, et al., T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment. Int J Radiat Oncol Biol Phys 2001; 51: 176-183. (Pubitemid 32758878)
24. Wiig JN, Waehre H, Larsen SG, Braendengen M, Giercksky KE,. Radical prostatectomy for locally advanced primary or recurrent rectal cancer. Eur J Surg Oncol 2003; 29: 455-458. (Pubitemid 36748590)